翡翠展覽會 EEX 深 滬
已收盤 02-06 16:00:00 美东时间
4.92
+0.070
+1.44%
華盛通- 最 高5.02
- 今 開4.86
- 成交量 4.11万股
- 最 低 4.835
- 昨 收 4.85
- 總市值 9.73亿
- 52周最高 5.435
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 3.17
- 委 比 0.00%
- 總股本 1.98亿
- 歷史最高 23.74
- 量 比 0.75
- 振 幅 3.81%
- 歷史最低 1.41
- 每 手 1
- 風險率 0.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Rosenblatt Maintains Buy on Emerald Holding, Maintains $7.7 Price Target
Rosenblatt analyst Barton Crockett maintains Emerald Holding (NYSE:EEX) with a Buy and maintains $7.7 price target.
2025-12-17 20:26
Cementos Pacasmayo, Rezolve AI, Emerald Holding And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
2025-12-16 23:53
Emerald Initiates Potential Strategic Options; Reiterates 2025 Revenue Guidance Between $460M To $465M
Emerald Holding, Inc. (NYSE: EEX) ("Emerald" or the "Company") announced that it has begun a review of potential strategic options following inquiries regarding a possible acquisition of the Company. Goldman Sachs &
2025-12-16 22:07
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
Emerald Expositions Events: Growth Amid Challenges in Earnings Call
Emerald Expositions Events (($EEX)) has held its Q3 earnings call. Read on for ...
2025-11-04 08:27
Rosenblatt Maintains Buy on Emerald Holding, Lowers Price Target to $7.7
Rosenblatt analyst Barton Crockett maintains Emerald Holding (NYSE:EEX) with a Buy and lowers the price target from $7.9 to $7.7.
2025-11-03 20:44
Earnings Scheduled For October 31, 2025
Companies Reporting Before The Bell • T. Rowe Price Group (NASDAQ:TROW) is esti...
2025-10-31 19:11
Emerald Holding Raises FY2025 Sales Guidance from $450.000M-$460.000M to $460.000M-$465.000M vs $462.900M Est
Emerald Holding (NYSE:EEX) raises FY2025 sales outlook from $450.000 million-$460.000 million to $460.000 million-$465.000 million vs $462.900 million estimate.
2025-10-31 18:27
Emerald Holding Q3 EPS $(0.07) Misses $(0.04) Estimate, Sales $77.500M Beat $76.750M Estimate
Emerald Holding (NYSE:EEX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.04) by 100 percent. This is a 40 percent decrease over losses of $(0.05) per share from the
2025-10-31 18:26
